Trial intelligence / Profile preview

Linaclotide for Bowel Preparation in Colonoscopy

NCT05291325Completed

Sponsor
Changhai Hospital
Start
May 2022
Primary completion
Aug 2023
Modality
Peptides
Countries
1
01

Overview

Randomised, single-blind trial of linaclotide in bowel preparation (3 arms), sponsored by Changhai Hospital. Primary endpoint: Bowel preparation adequate rate. Started May 2022; status: completed.

02

Drugs

linaclotide
03

Conditions

bowel preparation

Beyond the preview

Go deeper on NCT05291325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05291325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call